CPT code 83521 denotes a laboratory chemistry test that measures concentrations of free immunoglobulin light chains — kappa or lambda — in serum. These quantitative assays, often performed by turbidimetric methods, are clinically important for diagnosing and monitoring plasma‑cell disorders such as multiple myeloma and primary amyloidosis. Nationally, use of measurements for free light chains supports disease detection, therapeutic monitoring, and progression assessment across inpatient and outpatient laboratory settings.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes payer coverage patterns and benchmarking considerations, highlights relevant clinical context for test utilization, and outlines common service settings where the test is performed. Readers will find concise benchmarks for utilization and reimbursement patterns, an overview of clinical indications and testing methods, and notes on reporting and coding practice relevant to laboratory administrators and billing staff. Data not available in the input is indicated where applicable.